H Bozkurt, S Sahin - Turk Psikiyatri Dergisi, 2016 - search.proquest.com
Atomoxetine, a selective inhibitor of noradrenaline re-uptake, is the first non-stimulant drug
approved for the treatment of attention deficit hyperactivity disorder (ADHD). Beside ADHD, it …